Profiling the genome and proteome of metabolic dysfunction-associated steatotic liver disease identifies potential therapeutic targets.
Liu J, Hu S, Chen L, Daly C, Prada Medina CA, Richardson TG, Traylor M, Dempster NJ, Mbasu R, Monfeuga T, Vujkovic M, Tsao PS, Lynch JA, Voight BF, Chang KM, Million VA, Cobbold JF, Tomlinson JW, van Duijn CM, Howson JMM.
Liu J, et al. Among authors: tomlinson jw.
medRxiv [Preprint]. 2023 Nov 30:2023.11.30.23299247. doi: 10.1101/2023.11.30.23299247.
medRxiv. 2023.
PMID: 38076879
Free PMC article.
Preprint.